Donker ML - Search Results

1

Comparison of HiDAC Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome.

Tang MW, Van der Tuin D, Aydin M, Heijmans J, Van de Loosdrecht AA, Meijer E, Rutten CE, Wondergem M, Janssen JJWM, Donker ML, Hazenberg MD, Zweegman S, Biemond BJ, De Leeuw DC, Nur E. Tang MW, et al. Among authors: donker ml. Eur J Haematol. 2024 Dec 26. doi: 10.1111/ejh.14370. Online ahead of print. Eur J Haematol. 2024. PMID: 39726233

2

Midostaurin as the Most Likely Cause of Bilateral Adrenal Masses in a Patient with Acute Myeloid Leukemia.

Schutte T, Stege CAM, Smits MM, Franssen LE, Donker ML, de Leeuw DC. Schutte T, et al. Among authors: donker ml. Clin Drug Investig. 2022 Sep;42(9):791-797. doi: 10.1007/s40261-022-01186-y. Epub 2022 Aug 10. Clin Drug Investig. 2022. PMID: 35948754 Free PMC article. No abstract available.

3

Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients.

van Lier YF, Davids M, Haverkate NJE, de Groot PF, Donker ML, Meijer E, Heubel-Moenen FCJI, Nur E, Zeerleder SS, Nieuwdorp M, Blom B, Hazenberg MD. van Lier YF, et al. Among authors: donker ml. Sci Transl Med. 2020 Aug 12;12(556):eaaz8926. doi: 10.1126/scitranslmed.aaz8926. Sci Transl Med. 2020. PMID: 32801142

4

Evaluating ivosidenib for the treatment of acute myeloid leukemia.

Donker ML, Ossenkoppele GJ. Donker ML, et al. Expert Opin Pharmacother. 2020 Dec;21(18):2205-2213. doi: 10.1080/14656566.2020.1806822. Epub 2020 Aug 18. Expert Opin Pharmacother. 2020. PMID: 32808831 Free article. Review.

5

Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism.

Zondag W, den Exter PL, Crobach MJ, Dolsma A, Donker ML, Eijsvogel M, Faber LM, Hofstee HM, Kaasjager KA, Kruip MJ, Labots G, Melissant CF, Sikkens MS, Huisman MV; Hestia Study Investigators. Zondag W, et al. Among authors: donker ml. Thromb Haemost. 2013 Jan;109(1):47-52. doi: 10.1160/TH12-07-0466. Epub 2012 Nov 8. Thromb Haemost. 2013. PMID: 23138355

6

Biochemical markers predictive for bone marrow involvement in systemic mastocytosis.

Donker ML, van Doormaal JJ, van Doormaal FF, Kluin PM, van der Veer E, de Monchy JG, Kema IP, Kluin-Nelemans HC. Donker ML, et al. Haematologica. 2008 Jan;93(1):120-3. doi: 10.3324/haematol.11558. Haematologica. 2008. PMID: 18166795 Free article.

7

Treatment sequences and drug costs from diagnosis to death in multiple myeloma.

Seefat MR, Cucchi DGJ, Groen K, Donker ML, van der Hem KG, Westerman M, Gerrits AM, Beeker A, van de Donk NWCJ, Blommestein HM, Zweegman S. Seefat MR, et al. Among authors: donker ml. Eur J Haematol. 2024 Mar;112(3):360-366. doi: 10.1111/ejh.14119. Epub 2023 Oct 11. Eur J Haematol. 2024. PMID: 37821211

8

Two patients with osteoporosis: initial presentation of systemic mastocytosis.

Donker ML, Bakker NA, Jaspers WJ, Verhage AH. Donker ML, et al. J Bone Miner Metab. 2008;26(2):199-202. doi: 10.1007/s00774-007-0800-x. Epub 2008 Feb 27. J Bone Miner Metab. 2008. PMID: 18301978

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters